A compendium of mutational cancer driver genes F Martínez-Jiménez, F Muiños, I Sentís, J Deu-Pons, I Reyes-Salazar, ... Nature Reviews Cancer 20 (10), 555-572, 2020 | 826 | 2020 |
Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2 A Popa, JW Genger, MD Nicholson, T Penz, D Schmid, SW Aberle, ... Science translational medicine 12 (573), eabe2555, 2020 | 224 | 2020 |
Genomic and evolutionary classification of lung cancer in never smokers T Zhang, P Joubert, N Ansari-Pour, W Zhao, PH Hoang, R Lokanga, ... Nature genetics 53 (9), 1348-1359, 2021 | 109 | 2021 |
In silico saturation mutagenesis of cancer genes F Muiños, F Martínez-Jiménez, O Pich, A Gonzalez-Perez, N Lopez-Bigas Nature 596 (7872), 428-432, 2021 | 81 | 2021 |
Pan-cancer whole-genome comparison of primary and metastatic solid tumours F Martínez-Jiménez, A Movasati, SR Brunner, L Nguyen, P Priestley, ... Nature 618 (7964), 333-341, 2023 | 75 | 2023 |
Target Prediction for an Open Access Set of Compounds Active against Mycobacterium tuberculosis F Martínez-Jiménez, G Papadatos, L Yang, IM Wallace, V Kumar, ... PLOS computational biology 9 (10), e1003253, 2013 | 66 | 2013 |
Release of 50 new, drug-like compounds and their computational target predictions for open source anti-tubercular drug discovery MJ Rebollo-Lopez, J Lelièvre, D Alvarez-Gomez, J Castro-Pichel, ... PloS one 10 (12), e0142293, 2015 | 48 | 2015 |
A novel family of soluble minimal scaffolds provides structural insight into the catalytic domains of integral membrane metallopeptidases M López-Pelegrín, N Cerdà-Costa, F Martínez-Jiménez, A Cintas-Pedrola, ... Journal of Biological Chemistry 288 (29), 21279-21294, 2013 | 40 | 2013 |
Systematic analysis of alterations in the ubiquitin proteolysis system reveals its contribution to driver mutations in cancer F Martínez-Jiménez, F Muiños, E López-Arribillaga, N Lopez-Bigas, ... Nature Cancer 1 (1), 122-135, 2020 | 35 | 2020 |
Genetic immune escape landscape in primary and metastatic cancer F Martínez-Jiménez, P Priestley, C Shale, J Baber, E Rozemuller, ... Nature Genetics 55 (5), 820-831, 2023 | 33 | 2023 |
Ligand-target prediction by structural network biology using nAnnoLyze F Martínez-Jiménez, MA Marti-Renom PLOS computational biology 11 (3), e1004157, 2015 | 23 | 2015 |
Rational design of non-resistant targeted cancer therapies F Martínez-Jiménez, JP Overington, B Al-Lazikani, MA Marti-Renom Scientific reports 7 (1), 46632, 2017 | 19* | 2017 |
Detection of oncogenic and clinically actionable mutations in cancer genomes critically depends on variant calling tools CA Garcia-Prieto, F Martínez-Jiménez, A Valencia, E Porta-Pardo Bioinformatics 38 (12), 3181-3191, 2022 | 13* | 2022 |
Should network biology be used for drug discovery? F Martínez-Jiménez, MA Marti-Renom Expert Opinion on Drug Discovery 11 (12), 1135-1137, 2016 | 6 | 2016 |
Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium L Marcos-Villar, B Perdiguero, S Anthiya, ML Borrajo, G Lou, ... npj Vaccines 9 (1), 53, 2024 | 1 | 2024 |
An immunogenetic basis for lung cancer risk C Krishna, A Tervi, M Saffern, EA Wilson, SK Yoo, N Mars, V Roudko, ... Science 383 (6685), eadi3808, 2024 | 1 | 2024 |
Author Correction: Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium L Marcos-Villar, B Perdiguero, S Anthiya, ML Borrajo, G Lou, ... npj Vaccines 9, 2024 | | 2024 |
Assessment of Human SARS CoV-2-Specific T-Cell Responses Elicited In Vitro by New Computationally Designed mRNA Immunogens (COVARNA) I Esteban, C Pastor-Quiñones, L Usero, E Aurrecoechea, L Franceschini, ... Vaccines 12 (1), 15, 2023 | | 2023 |
Automatic interpretation of cancer genomes creates the largest repository of tumour genetic driver events FM Jiménez, F Muiños, O Pich, A González-Perez, N López-Bigas Annals of Oncology 30, v3, 2019 | | 2019 |
Structural study of the therapeutic potential of protein-ligand interactions FM Jimenez Universitat Pompeu Fabra, 2016 | | 2016 |